Purchase Order 75N94020P00550

This is a $18,243.50 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Cyagen Biomodels LLC, a for-profit biotechnology company in Santa Clara, California. The contract is for laboratory research to generate a mouse YWHAE (N terminal-EGFP) knockin project on a C57BL/6J genetic background. This specialized genetic engineering service supports advanced scientific investigations across multiple...

<p>The National Institute of Child Health and Human Development issued a purchase order to Cyagen US Inc. for $97,577 on September 14, 2020, for turboknockout mouse gene targeting services. Work is performed in Santa Clara, California. The order is firm fixed price with an ultimate completion date of June 22, 2021. The underlying solicitation was posted August 12, 2020, with a due date of August 21, 2020.</p>

This firm-fixed-price purchase order contract, valued at $13,594.30, was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Cyagen Biomodels LLC, a for-profit biotechnology company located in Santa Clara, California. The contract is for the generation of a TBX3 conditional knockout mouse strain to support biomedical research. No small business set-aside was used for this award. Cyagen Biomodels LLC specializes in...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cyagen Biosciences Inc., a self-certified small disadvantaged business. The $16,950.00 firm-fixed price purchase order is for &quot;CYAGEN BIOSCIENCE DOUBLE KNOCKOUT MOUSE PRODUCTION&quot; services. The contract does not have a set-aside designation and is set to conclude on September 15, 2014. Cyagen Biosciences Inc. is the prime contractor, and no major...

<p>The U.S. Department of Agriculture awarded a purchase order to Cyagen Biomodels LLC valued at $197,805 on August 18, 2025, to develop customized, gene-targeted mouse lines supporting the study of prion origin, transmission, and strain diversity in cervids and livestock. Work will be performed in Santa Clara, California under a firm fixed-price structure with completion targeted for February 26, 2027. The purchase order carries no small business set-aside.</p>

This is a firm fixed price purchase order awarded to Taconic Biosciences, Inc. (doing business as SAS Supply) by the National Institute of Child Health and Human Development (NICHD), a civilian agency, for the &quot;Mouse CNR1-ROSA26 Conditional Knockin Project&quot; in the amount of $21,589.00. The award has a completion date of June 30, 2024 and does not utilize any set-aside designations. Taconic Biosciences is a global leader in genetically engineered rodent models and services, and has been...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $121,347 firm fixed price purchase order to Cyagen Biomodels LLC of Santa Clara, California. The contract is for the generation of conditional knock-in and knock-out mouse models to support the agency's research focusing on the development of the mammalian hematopoietic system and study of signal transduction molecules and pathways that regulate T...

<p>The Office of Logistics and Acquisition Operations awarded a purchase order to the Board of Regents of the University of Nebraska valued at $15,002 for generation of a CRE-ERT2 knock-in mouse model for OCM gene using the EASI-CRISPR approach, with award date of September 8, 2018 and ultimate completion date of September 9, 2019. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price with no set-aside applied.</p>

This is a firm fixed price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotechnology company. The contract is for the delivery of specialized Kremen1-flox mice, which are a type of knockout mouse model, to support preclinical drug discovery and development research. The contract has a ceiling value of $13,509.55 and a completion date of November 19,...

This is a $249,167.58 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Gempharmatech LLC, a foreign-owned for-profit biotech company. The contract is for the development of humanized mouse models for nicotinamide N-methyltransferase (NNMT) and sulfotransferase (SULT1A1) using CRISPR knock-in technology. The contractor will conduct biochemical testing of inhibitors and...